Topline data presented yesterday (12 December) considered 36 patients eligible for safety and efficacy evaluation at 29 October ... NSCLC after immunotherapy is platinum-based doublet therapy. A study ...

Relation has announced two strategic collaborations with GSK, focusing on new therapeutics for fibrotic and osteoarthritis.

FDA agrees that the composite Unified Huntington’s Disease Rating Scale (cUHDRS) may serve as an intermediate clinical endpoint for Accelerated Approval ~ LEXINGTON, Mass. and AMSTERDAM, (GLOBE ...

An improved price discount and new evidence from Santhera has changed NICE’s tune following a recommendation shun earlier this year.

There are many myths surrounding hormone therapy in perimenopause. We consulted a doctor to sort fact from fiction ...

In addition, cells such as blood and bone marrow cells, mature, immature & solid tissue cells, adult stem cells, and embryonic stem cells are widely used in cell therapy procedures. Cell therapy ...